Fix it in documentation - prescription drugs

Consumer Reports and other outlets are reporting that Diabetes drugs Januvia, Janumet may pose dangerous risk. The article notes that there have been reports of 88 cases of acute pancreatitis in patients taking these drugs.
And, so how does the FDA tell the pharmaceutical manufacturer to deal with this dangerous side effect. By updating the documentation, of course.

We can be confident that the FDA is taking this very seriously. It's printing the guidelines to the healthcare professionals in bold text.

Information for Healthcare Professionals - Acute pancreatitis and sitagliptin (marketed as Januvia and Janumet)